Multi-Target Binding Profiles of Natural Polyphenols: Implications for Cellular Perfusion, Vascular Biology, and Cardiovascular Pathophysiology

Abstract

Natural polyphenols have emerged as potential multi-target agents in cardiovascular diseases due to their regulatory effects on oxidative stress, inflammation, and vascular signaling pathways. In this study, the binding profiles of six natural polyphenolic compounds—apigenin, gallic acid, kaempferol, luteolin, quercetin, and rosmarinic acid—toward protein targets associated with cellular perfusion, endothelial biology, and cardiovascular pathophysiology were evaluated using molecular docking analysis. Molecular docking analyses were performed using the UCSF Chimera and AutoDock Vina software packages. Six target proteins selected from the Protein Data Bank database included hypoxia-inducible factor prolyl hydroxylase (PHD2), neuropilin-1 (NRP1), the HIF-2α/ARNT heterodimer, ADAMTS4, the VEGFR2 kinase domain, and the VEGF-A receptor-binding domain. Binding affinities were evaluated based on the lowest binding energy values (kcal/mol) obtained from poses with RMSD = 0. According to the obtained results, binding energies ranged between −3.9 and −8.9 kcal/mol. Quercetin exhibited the strongest overall binding profile, demonstrating particularly high affinity toward the ADAMTS4 and PHD2 targets. Other flavonoid compounds, especially luteolin and apigenin, also displayed strong and balanced binding affinities across multiple targets. Rosmarinic acid showed selectively high binding affinity particularly toward the NRP1 target, whereas gallic acid generally exhibited lower binding affinities. In conclusion, these findings suggest that natural polyphenols may modulate interconnected processes such as hypoxia response, endothelial function, vascular remodeling, and extracellular matrix regulation through multiple molecular targets. This multi-target potential indicates that these compounds may serve as functional and therapeutic candidates in the context of cellular perfusion and cardiovascular pathophysiology. However, further advanced in vitro and in vivo studies are required to validate these findings.

Keywords

• Molecular docking
• Natural polyphenols
• Cardiovascular diseases
• Endothelial function
• Cellular perfusion
• Vascular biology

Ethical Statement

Ethics committee approval was not obtained as no studies on animals or humans were conducted in this study.

References

1. Amaç, B., & Göç, Ö. (2026). In silico investigation of the molecular-level interactions of phenolic compounds in propolis with the mechanosensitive Piezo1 channel. Black Sea Journal of Engineering and Science, 9(2), 633–645.
2. Amangeldinova, M., Ersatır, M., Necip, A., Cimentepe, M., Kudrina, N., Terletskaya, N., Öztürk, M., & Yildirim, M. (2025). Green extraction strategies and bioactivity of Rheum cordatum Losinsk: Antioxidant, antimicrobial, and molecular docking insights. Plants, 14(7), Article 1071. https://doi.org/10.3390/plants14071071
3. Appleton, B. A., Wu, P., Maloney, J., Yin, J., Liang, W. C., Stawicki, S., Hurt, F., Totpal, K., Ross, S., De Forge, L., Sutherlin, D., Lowman, H. B., Tarbujashvili, G., Meng, G., Fuh, G., & Wiesmann, C. (2007). Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding. The EMBO Journal, 26(23), 4902–4912. https://doi.org/10.1038/sj.emboj.7601905
4. Arshad, M., Ali, M., Maqsood, S., Ikram, A., Hossain, M., Aljameel, A., Al‐Farga, A., & Gnedeka, K. (2025). Dietary phytochemicals in cardiovascular disease prevention and management: A comprehensive review. Food Science & Nutrition, 13(2), 872–892. https://doi.org/10.1002/fsn3.70872
5. Bakleh, M., & Zen, A. (2025). The distinct role of HIF-1α and HIF-2α in hypoxia and angiogenesis. Cells, 14(9), Article 673. https://doi.org/10.3390/cells14090673
6. Cheng, B., Zhou, Y., Liu, J., Fei, X., Pan, W., Peng, X., Wang, W., & Chen, J. (2024). Recent progress in the development of hypoxia-inducible factor 2α (HIF-2α) modulators: Inhibitors, agonists, and degraders (2009-2024). European Journal of Medicinal Chemistry, 275, Article 116645. https://doi.org/10.1016/j.ejmech.2024.116645
7. De Savi, C., Pape, A., Cumming, J. G., Ting, A., Smith, P. D., Burrows, J. N., Mills, J. E., Davies, A. M., Redfearn, H. M., & Gerhardt, S. (2011). The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis. Bioorganic & Medicinal Chemistry Letters, 21(5), 1376–1381. https://doi.org/10.1016/j.bmcl.2011.01.018
8. Demirbağ, B., Yildirim, M., Cimentepe, M., Necip, A., Unver, H., & Tiftik, E. N. (2025). Novel vanillin-derived Schiff bases: Synthesis, characterization, antibacterial activity, enzyme inhibition, antioxidant activity, anti-inflammatory activity on LPS-induced RAW264.7 macrophage cell line, and in silico studies. Journal of Molecular Structure, 1338, Article 142320. https://doi.org/10.1016/j.molstruc.2025.142320

9. Dikme, R., & Necip, A. (2025). In silico assessment of amino acid–protein interactions in coronary artery disease: Molecular insights for functional biology. Black Sea Journal of Engineering and Science, 8(5), 1652–1658.
10. Dikme, T. G., Necip, A., Dikme, R., & Güneş, S. (2024). Effect of phytosterols in apricot kernel on cholesterol: Molecular docking. Mehes Journal, 2(3), 28–38.
11. Frąk, W., Wojtasińska, A., Lisińska, W., Młynarska, E., Franczyk, B., & Rysz, J. (2022). Pathophysiology of cardiovascular diseases: New insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease. Biomedicines, 10(8), Article 1938. https://doi.org/10.3390/biomedicines10081938
12. İzol, E., Beltekin, B., Turhan, M., Karakoç, Ş., Necip, A., Yılmaz, M. A., Ertürk, M., & Çakır, O. (2026). Comprehensive exploration of three pistachio varieties: Antidiabetic, anticholinergic, antioxidant properties, phytochemical profile by LC–MS/MS, and molecular docking. Food Science & Nutrition, 14(3), Article e71656. https://doi.org/10.1002/fsn3.71656
13. İzol, E., Turhan, M., Yapıcı, İ., Necip, A., Yılmaz, M. A., & Zengin, G. (2025). Research of Peganum harmala: Phytochemical content, mineral profile, antioxidant, antidiabetic, anticholinergic properties, and molecular docking. Chemistry & Biodiversity, 22(7), Article e202403178. https://doi.org/10.1002/cbdv.202403178
14. Karakaya, A., Acar Çevik, U., Kaya, B., Çiftçi, B., Necip, A., Işık, M., Türkeş, C., Beydemir, Ş., & Kaplancıklı, Z. A. (2025). Design, synthesis, in silico absorption, distribution, metabolism, and elimination and molecular docking studies of thiazole‐based furan derivatives, and their biological evaluation for Alzheimer disease therapy. ChemistryOpen, 14(12), Article e202500305. https://doi.org/10.1002/open.202500305
15. Key, J., Scheuermann, T. H., Anderson, P. C., Daggett, V., & Gardner, K. H. (2009). Principles of ligand binding within a completely buried cavity in HIF2α PAS-B. Journal of the American Chemical Society, 131(48), 17647–17654. https://doi.org/10.1021/ja9073147
16. Lampropoulou, A., & Ruhrberg, C. (2014). Neuropilin regulation of angiogenesis. Biochemical Society Transactions, 42(6), 1623–1628. https://doi.org/10.1042/bst20140244
17. Li, W., Liu, E., Zhou, Y., Liao, Z., & Wang, D. (2025). Therapeutic potential of natural products in ischemic stroke: Targeting angiogenesis. Frontiers in Pharmacology, 16, Article 1579172. https://doi.org/10.3389/fphar.2025.1579172
18. Li, X., Ji, Z., Qiu, X., & Fan, Q. (2012). Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and matrix metalloproteinase-2 in sacral chordomas. Oncology Letters, 3(6), 1268–1274. https://doi.org/10.3892/ol.2012.645
19. Lungu, C., & Mehedinți, M. (2023). Molecular motifs in vascular morphogenesis: Vascular Endothelial Growth Factor A (VEGFA) as the leading promoter of angiogenesis. International Journal of Molecular Sciences, 24(15), Article 12169. https://doi.org/10.3390/ijms241512169
20. McDonough, M. A., Li, V., Flashman, E., Chowdhury, R., Mohr, C., Liénard, B. M., Hofbauer, J., Lauder, M. A., Tyler, T. W., & Schofield, C. J. (2006). Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2). Proceedings of the National Academy of Sciences, 103(26), 9814–9819. https://doi.org/10.1073/pnas.0601859103
21. McTigue, M., Murray, B. W., Chen, J. H., Deng, Y. L., Solowiej, J., & Kania, R. S. (2012). Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors. Proceedings of the National Academy of Sciences, 109(45), 18281–18289. https://doi.org/10.1073/pnas.1207599109
22. Mensah, G. A., Fuster, V., Murray, C. J. L., Roth, G. A., Sharifan, A., Zeng, Y., Mehrabani-Zeinabad, K., & GBD 2022 Cardiovascular Risk Factors Collaborators. (2023). Global burden of cardiovascular diseases and risks, 1990-2022. Journal of the American College of Cardiology, 82(25), 2350–2473. https://doi.org/10.1016/j.jacc.2023.11.007
23. Monaci, S., Coppola, F., Filippi, I., Falsini, A., Carraro, F., & Naldini, A. (2024). Targeting hypoxia signaling pathways in angiogenesis. Frontiers in Physiology, 15Trace, Article 1408750. https://doi.org/10.3389/fphys.2024.1408750
24. Necip, A. (2024). Kardiyovasküler hastalıklarda doğal ürünler: Kurkumin ve quercetin moleküler docking [Natural products in cardiovascular diseases: Curcumin and quercetin molecular docking]. Mehes Journal, 2(1), 1–9.
25. Necip, A. (2025). Natural remedies for type 2 diabetes: Evaluation of phytochemicals with bioinformatics and molecular approaches/ADME/T analysis. Cumhuriyet Science Journal, 46(2), 329–337. https://doi.org/10.37775/csj.1504123
26. Necip, A., Işık, M., Türkeş, C., Ünal, D., Kırboğa, K. K., Beydemir, Ş., & Rudrapal, M. (2026). Marine algae-derived polyamines and phlorotannins as cholinesterase inhibitors: In vitro and in silico analysis. Biocatalysis and Agricultural Biotechnology, 72, Article 104035. https://doi.org/10.1016/j.bcab.2026.104035
27. Strowitzki, M., Cummins, E., & Taylor, C. (2019). Protein hydroxylation by Hypoxia-Inducible Factor (HIF) hydroxylases: Unique or ubiquitous?. Cells, 8(5), Article 384. https://doi.org/10.3390/cells8050384
28. Tonolo, F., Grinzato, A., Bindoli, A., & Rigobello, M. (2023). From in silico to a cellular model: Molecular docking approach to evaluate antioxidant bioactive peptides. Antioxidants, 12(3), Article 6665. https://doi.org/10.3390/antiox12030665
29. Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
30. Ungvari, Z., Tarantini, S., Kiss, T., Wren, J. D., Giles, C. B., Griffin, C. T., Murfee, W. L., Pacher, P., & Csiszar, A. (2018). Endothelial dysfunction and angiogenesis impairment in the ageing vasculature. Nature Reviews Cardiology, 15(9), 555–565. https://doi.org/10.1038/s41569-018-0030-z
31. Wang, X., & He, B. (2024). Endothelial dysfunction: Molecular mechanisms and clinical implications. MedComm, 5(6), Article e651. https://doi.org/10.1002/mco2.651
32. Xu, S., Ilyas, I., Little, P. J., Li, H., Kamato, D., Zheng, X., Luo, S., Li, Z., Liu, P., Han, J., Harding, I. C., Ebong, E. E., Cameron, S. J., Stewart, A. G., & Weng, J. (2021). Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: From mechanism to pharmacotherapies. Pharmacological Reviews, 73(3), 924–967. https://doi.org/10.1124/pharmrev.120.000096
33. Yildirim, M., Necip, A., Cimentepe, M., Emire, Z., & Yabalak, E. (2025). Bioactive potential of Origanum munzurense Kit Tan & Sorger extracts: Antioxidant, anticancer, and antibacterial activities explored through Sc-CO2 extraction and molecular docking analysis. Journal of Chromatography B, 1259, Article 124614. https://doi.org/10.1016/j.jchromb.2025.124614
34. Zhang, M., Liu, Q., Meng, H., Duan, H., Liu, X., Wu, J., Gao, F., Wang, S., Tan, R., & Yuan, J. (2024). Ischemia-reperfusion injury: Molecular mechanisms and therapeutic targets. Signal Transduction and Targeted Therapy, 9(1), Article 6. https://doi.org/10.1038/s41392-023-01688-x